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Asian populations have a higher body fat percentage for a given body mass index (BMI) than Caucasians.
However, little information is available on the association of BMI with ischemic heart disease (IHD) incidence in
Asians at low BMI levels. The authors prospectively evaluated the association of BMI (weight (kg)/height (m)2) with
IHD incidence over 9 years of follow-up (1993–2001) among 133,740 South Korean adults (89,050 men, 44,690
women) who participated in the 1990 and 1992 examinations of the Korea Medical Insurance Corporation Study.
Average BMI at baseline was 23.4 (standard deviation, 2.3) in men and 22.3 (standard deviation, 2.3) in women.
After multivariate adjustment, there was a 14% (95% conﬁdence interval: 12, 16) increased risk of incident IHD per
unit of increase in BMI. This trend was also observed within the range considered normal by Western standards,
and a BMI of 24–<25 was associated with an IHD hazard ratio of 2.01 (95% conﬁdence interval: 1.32, 3.05) in
comparison with a BMI of 18–<19. The association of BMI with IHD in this cohort of relatively young South Korean
men and women was progressive over the range of BMI values, with no threshold of change in risk and no
indication of a U-shaped relation at low BMI levels.
Asian continental ancestry group; body mass index; body weight; myocardial ischemia; obesity
Abbreviations: BMI, body mass index; CI, conﬁdence interval; KMIC, Korea Medical Insurance Corporation.
Excess adiposity is associated with a variety of health
risks, including an increased incidence of cardiovascular
events (1–3). To facilitate clinical decision-making and pub-
lic health interventions, standard body mass index (BMI;
weight (kg)/height (m)2) thresholds have been established
to define overweight (BMI 25–<30) and obesity (BMI30)
(1). However, these cutoffs were derived from studies per-
formed in Western countries, primarily in Caucasian sub-
jects, and they may not be appropriate for other racial/ethnic
groups (4, 5). Specifically, several Asian populations have
a higher body fat percentage for a given BMI than Cauca-
sians (4, 6, 7). Furthermore, while the prevalence of obesity
and overweight in some Asian populations is low by
Western criteria, diabetes, hypertension, and dyslipidemia
occur at lower BMI levels in these populations than in
Caucasians (7–12). Indeed, based on the association of in-
creasing BMI with these risk factors, a World Health Orga-
nization Expert Consultation recently introduced 23 as
a new BMI cutoff for public health action in Asian popula-
tions (6). Hence, the excess risk of ischemic heart disease
associated with increased weight in Asian populations may
occur well below a BMI of 25. However, previous studies of
BMI and ischemic heart disease in Asian populations have
not provided a detailed evaluation of the dose-response
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relation of body weight to disease endpoints or have been
limited to mortality endpoints (6, 13–18).
The objective of this study was to evaluate the association
between BMI and the incidence of ischemic heart disease
events in a large cohort of South Korean men and women.
We were particularly interested in the dose-response relation
at BMI levels below conventional diagnostic thresholds
used in Western populations.
MATERIALS AND METHODS
Study population
The Korea Medical Insurance Corporation (KMIC) Study
is a prospective study of cardiovascular risk factors in South
Korean men and women. Detailed descriptions of this co-
hort have been published previously (19–21). KMIC is a
provider of health insurance to civil service workers, teach-
ers, and their dependants in the Republic of Korea (South
Korea). In 1990, KMIC insured 11 percent of the South
Korean population. All insured workers are required to
participate in biennial medical examinations performed by
KMIC. In 1990 and 1992, 95 percent and 94 percent of
workers completed the examinations, respectively. Among
insured workers aged 35–59 years who attended both the
1990 and 1992 biennial examinations, we selected for in-
clusion in the KMIC cohort all female workers (n¼ 62,657)
and a 25 percent systematic random sample of male workers
(n ¼ 106,803).
We excluded 183 participants who died before January 1,
1993; 6,288 participants with cardiovascular disease, liver
disease, or cancer at or prior to the 1992 visit; 2,475 partic-
ipants for whom the average of 1990 and 1992 liver enzyme
(glutamic-oxaloacetic transaminase or glutamic pyruvic
transaminase) levels was above 70 IU; 9,430 participants
whose BMI changed by more than two units between the
1990 visit and the 1992 visit; and 1,834 participants for
whom the average of the 1990 and 1992 BMI measurements
was below 18. We also excluded 2,306 participants with
missing BMI data in 1990 or 1992, as well as 13,204 sub-
jects with missing data for any adjustment covariate. Thus,
the final sample size for this study was 133,740 (89,050 men
and 44,690 women).
Baseline data collection
Baseline data were collected at the 1990 and 1992 bien-
nial KMIC examinations, which were conducted in a stan-
dardized fashion by medical staff at 416 local hospitals
throughout South Korea. Weight, height, blood pressure,
and levels of total cholesterol, fasting glucose, and liver
enzymes (glutamic-oxaloacetic transaminase and glutamic
pyruvic transaminase) were measured at both the 1990 and
1992 medical examinations. BMI was calculated as weight
in kilograms divided by height in meters squared. Systolic
and diastolic blood pressure measurements were taken once
at each examination in the seated position by a registered
nurse or a blood pressure technician. A fasting serum spec-
imen was drawn and analyzed for total cholesterol and
glucose concentrations. Each participating hospital had in-
ternal and external quality control procedures directed by
the Korean Association of Laboratory Quality Control. In
our analyses, values for baseline BMI, systolic and diastolic
blood pressure, total cholesterol, and fasting glucose were
the average of measurements taken in 1990 and 1992. In-
formation on smoking history, frequency of alcohol drink-
ing, physical activity, and previous comorbidity was
obtained by questionnaire at the 1992 visit. Completed
questionnaires were reviewed and edited by trained staff
who followed the KMIC data collection procedures.
Outcome deﬁnition and follow-up procedures
The study outcomes were hospitalization and mortality
from acute myocardial infarction (International Classifica-
tion of Diseases, Ninth Revision, code 410; International
Classification of Diseases, Tenth Revision, codes I21–I22)
TABLE 1. Baseline characteristics of the study population,
Korea Medical Insurance Corporation Study, South Korea,
1990–1992
Characteristic
Men
(n ¼ 89,050)
Women
(n ¼ 44,690)
Mean age (years) 44.8 (6.7)* 42.1 (6.0)
Mean body mass indexy 23.4 (2.3) 22.3 (2.3)
Mean systolic blood
pressure (mmHg) 125.0 (13.7) 115.8 (12.1)
Mean diastolic blood
pressure (mmHg) 81.8 (9.4) 75.3 (8.7)
Mean total cholesterol
level (mg/dl) 194.0 (32.6) 188.4 (32.1)
Mean fasting glucose
level (mg/dl) 92.9 (20.8) 86.2 (12.9)
Smoking (%)
Never smoker 21.2 99.3
Past smoker 20.9 0.4
Current smoker
1–9 cigarettes/day 15.4 0.2
10–19 cigarettes/day 24.0 0.1
20 cigarettes/day 18.5 0.0
Frequency of alcohol
drinking (%)
Never 26.4 91.1
Occasionally 49.8 8.5
Often 23.8 0.4
Physical activity (%) 31.4 16.2
Hypertensivez (%) 26.7 9.4
Hypercholesterolemicz (%) 8.4 6.5
Diabeticz (%) 4.2 1.1
* Numbers in parentheses, standard deviation.
yWeight (kg)/height (m)2.
z Hypertensionwas deﬁnedas systolic blood pressure140mmHg
or diastolic blood pressure 90 mmHg, hypercholesterolemia as total
cholesterol240mg/dl, anddiabetes as fasting glucose126mg/dl or
previous diagnosis of diabetes.
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and ischemic heart disease (International Classification of
Diseases, Ninth Revision, codes 410–414 and 429.2; Inter-
national Classification of Diseases, Tenth Revision, codes
I20–I25). Follow-up extended for 9 years (January 1, 1993–
December 31, 2001). Hospitalization data were obtained
from hospital discharge summaries, coded by professionally
trained and certified medical chart recorders. Discharge
charts were coded in a standardized fashion using World
Health Organization criteria. Ascertainment of events re-
quiring hospitalization among KMIC enrollees is consid-
ered nearly complete, since hospitals could not receive
payment until the bill with the discharge diagnoses was sub-
mitted to KMIC. Mortality data were obtained from com-
puterized searches of death certificates from the Korean
National Statistical Office and are also likely to be nearly
complete. Death certificates were completed by trained
and certified recorders using information provided by
physicians.
Statistical analysis
Cox proportional hazards models were used to evaluate
the association of baseline BMI with the incidence of ische-
mic heart disease events over the 9 years of follow-up (22).
In the main analysis, we grouped BMI in one-unit categories
to avoid the assumption of linear effects of BMI on disease
endpoints. We performed subgroup analyses by sex and by
smoking status in men (current smokers vs. those not cur-
rently smoking). For subgroup analyses and analyses of fatal
events, we modeled BMI using restricted quadratic splines
in Cox models because of the limited number of events for
a fine categorization (23). The knots for the restricted
quadratic splines were set at 21, 23, 25, and 27 BMI units
(kg/m2). This parameterization of BMI requires only four
parameters, and it can accommodate a wide variety of
smooth dose-response curves. We conducted tests for lin-
ear trend by including in the regression model a variable
TABLE 2. Hazard ratios for incident ischemic heart disease and acute myocardial infarction by body mass index category, Korea
Medical Insurance Corporation Study, South Korea, 1993–2001
Body mass
index*
No. of
subjects
%
Ischemic heart disease Acute myocardial infarction
No. of
events
Model 1y Model 2z No. of
events
Model 1y Model 2z
HR§ 95% CI§ HR 95% CI HR 95% CI HR 95% CI
18–<19 4,100 3.1 24 1.00{ 1.00{ 8 1.00{ 1.00{
19–<20 9,159 6.8 68 1.17 0.74,
1.87
1.13 0.71,
1.80
22 1.07 0.48,
2.41
1.01 0.45,
2.26
20–<21 15,127 11.3 123 1.20 0.77,
1.85
1.11 0.72,
1.72
42 1.12 0.53,
2.40
0.99 0.47,
2.12
21–<22 19,104 14.3 193 1.40 0.91,
2.24
1.26 0.82,
1.92
72 1.41 0.68,
2.92
1.19 0.57,
2.48
22–<23 21,114 15.8 238 1.47 0.97,
2.24
1.25 0.82,
1.90
74 1.23 0.59,
2.54
0.95 0.46,
1.98
23–<24 20,564 15.4 327 1.97 1.30,
2.99
1.62 1.07,
2.45
113 1.80 0.88,
3.70
1.34 0.65,
2.76
24–<25 17,633 13.2 298 2.01 1.32,
3.05
1.58 1.04,
2.40
111 1.96 0.95,
4.02
1.39 0.67,
2.85
25–<26 11,932 8.9 242 2.39 1.57,
3.64
1.82 1.20,
2.78
82 2.09 1.01,
4.32
1.43 0.69,
2.97
26–<27 7,349 5.5 163 2.61 1.70,
4.02
1.91 1.24,
2.95
57 2.37 1.13,
4.97
1.53 0.73,
3.22
27–<28 4,063 3.0 115 3.26 2.10,
5.07
2.30 1.47,
3.58
41 3.00 1.41,
6.42
1.84 0.86,
3.96
28–<29 1,982 1.5 56 3.29 2.04,
5.32
2.26 1.40,
3.66
24 3.68 1.65,
8.20
2.22 0.99,
4.96
29–<30 960 0.7 28 3.54 2.05,
6.11
2.36 1.36,
4.86
10 3.31 1.30,
8.39
1.91 0.75,
4.87
30 653 0.5 24 4.37 2.48,
7.69
2.75 1.55,
4.86
10 4.87 1.92,
12.34
2.60 1.02,
6.62
p for linear
trend <0.001 <0.001 <0.001 <0.001
* Weight (kg)/height (m)2.
y Hazard ratios were adjusted for age, sex, smoking (never smoker, past smoker, or current smoker of 1–9, 10–19, or 20 cigarettes/day), frequency of alcohol
drinking (never, occasionally, or often), physical activity, and insurance premium (four categories).
z Hazard ratios were further adjusted for hypertension (systolic blood pressure 140 mmHg or diastolic blood pressure 90 mmHg), diabetes (fasting glucose
126 mg/dl or previous diagnosis of diabetes), and total cholesterol levels.
§ HR, hazard ratio; CI, conﬁdence interval.
{ Reference category.
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incorporating the median BMI of each category. The statis-
tical significance of interactions was evaluated using likeli-
hood ratio tests comparing models with and without the
interaction terms. All models included adjustment for age,
sex, smoking history, alcohol drinking frequency, physical
activity, and insurance premium (a surrogate marker of
socioeconomic status). In addition, we also fitted models
with further adjustment for hypertension (systolic blood pres-
sure 140 mmHg or diastolic blood pressure 90 mmHg),
diabetes (fasting glucose level126 mg/dl or previous diag-
nosis of diabetes mellitus), and total cholesterol levels to
evaluate the effect of BMI that is not explained by traditional
risk factors. Statistical analyses were performed using S-Plus
(MathSoft, Inc., Seattle, Washington) (24).
RESULTS
The average BMI of the study participants was 23.4 (stan-
dard deviation, 2.3) in men and 22.3 (standard deviation,
2.3) in women (table 1); 75.7 percent of men and 88.2
percent of women had a BMI below 25. Among men, the
age-adjusted average BMI was 0.32 units (95 percent con-
fidence interval (CI): 0.29, 0.35) lower in current smokers
than in those not currently smoking. The age- and smoking-
adjusted prevalences of hypertension, hypercholesterol-
emia, and diabetes increased progressively with BMI in both
men and women (p < 0.001 for all linear trends).
Over 9 years of follow-up, there were 1,899 incident cases
of ischemic heart disease (1,586 in males, 313 in females),
including 666 cases of acute myocardial infarction (621 in
males, 45 in females). There were 209 deaths from ischemic
heart disease (198 in males, 11 in females), including 181
deaths from acute myocardial infarction (172 in males, 9 in
females).
As table 2 shows, there were strong, graded relations of
increasing BMI with ischemic heart disease and myocardial
infarction. On average, there was a 14 percent (95 percent
CI: 12, 16) increased risk of incident ischemic heart disease
FIGURE 1. Nine-year cumulative incidence of ischemic heart
disease (IHD) and acute myocardial infarction (AMI) by body mass
index (weight (kg)/height (m)2) in men and women, Korea Medical
Insurance Corporation Study, South Korea, 1993–2001. Risk trends
were estimated from restricted quadratic spline Cox models adjusted
for age, smoking, frequency of alcohol drinking, physical activity, and
insurance premium. The bars represent the frequency distribution of
body mass index among men and women.
FIGURE 2. Nine-year cumulative incidence of ischemic heart
disease (IHD) and acute myocardial infarction (AMI) by body mass
index (weight (kg)/height (m)2) and smoking category (current
smokers vs. those not currently smoking) in men, Korea Medical
Insurance Corporation Study, South Korea, 1993–2001. Risk trends
were estimated from restricted quadratic spline Cox models adjusted
for age, frequency of alcohol drinking, physical activity, and insurance
premium. The bars represent the frequency distribution of body mass
index by smoking category in men.
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per unit of increase in BMI. This trend was also observed
across the lower part of the BMI range, with a twofold rise
(hazard ratio¼ 2.01, 95 percent CI: 1.32, 3.05) in the risk of
ischemic heart disease events from the category 18–<19 to
the category 24–<25. After adjustment for hypertension,
diabetes, and total cholesterol levels (table 2), the relation
of BMI with ischemic heart disease remained highly signif-
icant, albeit attenuated.
The direct and progressive associations of BMI with
ischemic heart disease and myocardial infarction were ob-
served in both men and women (figure 1), with no evidence
of different risk trends by sex (p values for the effects of
interaction between BMI and sex on the risks of ischemic
heart disease and myocardial infarction were 0.77 and 0.84,
respectively). Among men, the associations were also sim-
ilar in current smokers and those not currently smoking
(figure 2) (p values for the effects of interaction between
BMI and smoking status on the risks of ischemic heart
disease and myocardial infarction were 0.07 and 0.20,
respectively).
Because of the small number of fatal events in women,
the analyses of fatal endpoints were restricted to men. For
fatal cases, the dose-response relation increased gradually
throughout the entire range of BMI values (figure 3), with an
11 percent (95 percent CI: 5, 18) increased risk of death
from ischemic heart disease per unit of increase in BMI.
DISCUSSION
In our large cohort of South Korean men and women,
BMI was strongly related to the incidence of ischemic heart
disease, including acute myocardial infarction, throughout
its entire range. A BMI of 24–<25, considered normal by
Western standards, was still associated with double the
risk of ischemic heart disease in comparison with a BMI
of 18–<19. The excess risk associated with increased BMI
persisted after adjustment for hypertension, hypercholester-
olemia, and diabetes.
In a meta-analysis of the predictive ability of BMI to
estimate percent body fat across different ethnic groups,
Deurenberg et al. (4) estimated that for the same percent-
age of body fat, subjects from different East Asian coun-
tries would have BMIs 1.9–3.2 units lower than those of
Caucasians. While the precise reasons for these differen-
ces are not completely understood (6), Asians tend to have
a more slender body build than Caucasians, and slimmer
subjects tend to have less muscle mass and connective
tissue than stockier subjects (25). The shorter relative
leg length in Asians compared with Caucasians has also
been suggested as a possible explanation for these differ-
ences (4). In addition, Asian populations may have a dif-
ferent fat distribution pattern than Western populations
and may be more prone to central obesity, even at low
BMI levels (6, 9). Such considerations raise the possibility
that the risks associated with adiposity at lower levels of
BMI are higher in Asian populations and that BMI thresh-
olds derived from Caucasian populations do not apply to
Southeast Asian populations.
On the basis of these considerations, a recent World
Health Organization Expert Consultation introduced a new
BMI cutoff of 23 for public health action in Asian popula-
tions (6). While the expert committee recognized the con-
tinuum of increased risk with increasing BMI, its decision is
controversial because it was not directly supported by mor-
tality data (26, 27). Our results indicate a continuous, strong,
and graded relation between BMI and ischemic heart dis-
ease incidence throughout the entire BMI range, without
specific thresholds of abrupt change in risk and without
a U-shaped relation at low BMI levels. Our findings are
consistent with those of available studies containing detailed
information on the relation between BMI and ischemic heart
disease mortality (13, 18). This information should be in-
corporated into decision analytic models to evaluate the
cost-effectiveness of alternative BMI cutoffs for public
health action in different populations. It further indicates
that traditional risk factors provide only a partial image of
the risks associated with increases in BMI below conven-
tional thresholds.
The findings of our study may also be relevant to Western
populations. Because of the obesity epidemic, the BMI dis-
tribution in Western populations has shifted towards higher
values (1). The average BMIs of US adult men and women
aged 40 years in the 1999–2002 National Health and
Nutrition Examination Survey were 28.4 and 28.6,
respectively, with only 8.1 percent of men and 14.4 percent
of women having a BMI below 22 (28, 29). It is thus difficult
to identify large numbers of Western subjects with low BMI,
even in large cohorts, and we speculate that the low BMI
group in most Western studies overrepresents subjects with
preexisting conditions who are at increased risk of mortality.
As a consequence, the association between BMI and disease
risk at low BMI levels may be underestimated in Western
populations (30, 31).
FIGURE 3. Nine-year risk of death from ischemic heart disease
(IHD) and acute myocardial infarction (AMI) by body mass index
(weight (kg)/height (m)2) in men, Korea Medical Insurance Corpora-
tion Study, South Korea, 1993–2001. Risk trends were estimated from
restricted quadratic spline Cox models adjusted for age, smoking,
frequency of alcohol drinking, physical activity, and insurance pre-
mium. The bars represent the frequency distribution of body mass
index among men.
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The strengths of our study include a large sample size, the
use of two biennial examinations to establish a more stable
baseline, and the attempt to control for conditions that may
affect BMI and mortality simultaneously (30, 31), including
liver disease and nonintentional weight loss. In addition,
exclusion of participants with more than two units of differ-
ence in BMI between 1990 and 1992 is likely to have re-
duced random variability, since highly disparate measures
may also be the consequence of measurement error. How-
ever, some limitations must be considered in the interpreta-
tion of our findings. We lacked information on measures of
abdominal adiposity, such as waist circumference, and we
could not determine whether the increased risk associated
with increased BMI depended on overall adiposity or on
specific adipose tissue distribution patterns. We also lacked
information on treatment of hypertension and hypercholes-
terolemia, and thus control for these two conditions was
imperfect. In addition, outcome ascertainment was based
on administrative claims data and death certificate informa-
tion. These sources of error, however, are most likely non-
differential and will tend to reduce the estimated effect of
increased BMI. Finally, the association of BMI with cardio-
vascular disease is stronger in younger subjects than in
elderly subjects (32). Thus, our findings may not be gener-
alizable to older Asian populations.
In conclusion, our data provide strong evidence that the
association between BMI and ischemic heart disease is
graded throughout the entire BMI range, with no apparent
thresholds even at low BMI levels and no indication of
a U-shaped relation at low BMI levels.
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